Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens
Abstract In the battle against clinical infections particularly the resistant pathogens, the creation of new antimicrobial drugs is essential. This study focuses on synthesis and characterization of Lipase-CuO nanoparticle conjugates in order to investigate their antibacterial efficiency. Lipase enz...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Biotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12896-025-00950-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861835669962752 |
|---|---|
| author | Eman M. Handak Dina H. Amin Mai M. Elhateir |
| author_facet | Eman M. Handak Dina H. Amin Mai M. Elhateir |
| author_sort | Eman M. Handak |
| collection | DOAJ |
| description | Abstract In the battle against clinical infections particularly the resistant pathogens, the creation of new antimicrobial drugs is essential. This study focuses on synthesis and characterization of Lipase-CuO nanoparticle conjugates in order to investigate their antibacterial efficiency. Lipase enzyme and CuO nanoparticles were synthesized biologically by specific selected fungal strains. Statistical optimization of lipase enzyme was done using a Plackett-Burman design giving two enhancement models for lipase production with increasing in productivity up to 143.43% (2800 U/ml). Copper oxide (CuO) nanoparticles were characterized using visual indication of greenish color formation, UV-vis spectrum analysis which revealed a strong peak at 300 nm. Also, CuO nanoparticles appeared as distinct, well-dispersed spherical particles with average size of 71.035 nm using TEM, while conjugate appears as large protein molecules linked to the nanoparticles. Also, using techniques like energy dispersive X-ray (EDAX) the resultant conjugates formation was confirmed as the elemental analysis approved its formation. The antimicrobial activity of Lipase-CuO nanoparticles conjugates was tested against a range of clinical pathogens. The results demonstrated a significant increase in antimicrobial potency compared to both CuO nanoparticles and lipase alone particularly against E. coli strain NRC B-3703 with remarkable increase of 373.6% and 75% followed by S. aureus with increase of 50 and 42.8%compared to that of individual CuO nanoparticles and lipase enzyme, respectively. These findings suggest that Lipase-CuO nanoparticle conjugates hold great promise as a novel antimicrobial strategy, offering a potential solution to combat bacterial infections, especially those caused by multidrug-resistant strains. The study highlights the importance of nanotechnology in enhancing the efficacy of traditional antimicrobial agents and opens new avenues for targeted antimicrobial therapies. |
| format | Article |
| id | doaj-art-ae818e6b8e4f4de48a197b5a4bd56c86 |
| institution | Kabale University |
| issn | 1472-6750 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Biotechnology |
| spelling | doaj-art-ae818e6b8e4f4de48a197b5a4bd56c862025-02-09T12:43:42ZengBMCBMC Biotechnology1472-67502025-02-0125111810.1186/s12896-025-00950-0Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogensEman M. Handak0Dina H. Amin1Mai M. Elhateir2Botany and Microbiology Department, Faculty of Science, Al-Azhar University (Girls Branch)Microbiology Department, Faculty of Science, Ain Shams UniversityBotany and Microbiology Department, Faculty of Science, Al-Azhar University (Girls Branch)Abstract In the battle against clinical infections particularly the resistant pathogens, the creation of new antimicrobial drugs is essential. This study focuses on synthesis and characterization of Lipase-CuO nanoparticle conjugates in order to investigate their antibacterial efficiency. Lipase enzyme and CuO nanoparticles were synthesized biologically by specific selected fungal strains. Statistical optimization of lipase enzyme was done using a Plackett-Burman design giving two enhancement models for lipase production with increasing in productivity up to 143.43% (2800 U/ml). Copper oxide (CuO) nanoparticles were characterized using visual indication of greenish color formation, UV-vis spectrum analysis which revealed a strong peak at 300 nm. Also, CuO nanoparticles appeared as distinct, well-dispersed spherical particles with average size of 71.035 nm using TEM, while conjugate appears as large protein molecules linked to the nanoparticles. Also, using techniques like energy dispersive X-ray (EDAX) the resultant conjugates formation was confirmed as the elemental analysis approved its formation. The antimicrobial activity of Lipase-CuO nanoparticles conjugates was tested against a range of clinical pathogens. The results demonstrated a significant increase in antimicrobial potency compared to both CuO nanoparticles and lipase alone particularly against E. coli strain NRC B-3703 with remarkable increase of 373.6% and 75% followed by S. aureus with increase of 50 and 42.8%compared to that of individual CuO nanoparticles and lipase enzyme, respectively. These findings suggest that Lipase-CuO nanoparticle conjugates hold great promise as a novel antimicrobial strategy, offering a potential solution to combat bacterial infections, especially those caused by multidrug-resistant strains. The study highlights the importance of nanotechnology in enhancing the efficacy of traditional antimicrobial agents and opens new avenues for targeted antimicrobial therapies.https://doi.org/10.1186/s12896-025-00950-0Antimicrobial agentsClinical pathogensLipase-CuO nanoparticlesStatistical optimization |
| spellingShingle | Eman M. Handak Dina H. Amin Mai M. Elhateir Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens BMC Biotechnology Antimicrobial agents Clinical pathogens Lipase-CuO nanoparticles Statistical optimization |
| title | Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens |
| title_full | Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens |
| title_fullStr | Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens |
| title_full_unstemmed | Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens |
| title_short | Design and assessment of lipase-CuO nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens |
| title_sort | design and assessment of lipase cuo nanoparticle conjugates for enhanced antimicrobial efficacy against clinical pathogens |
| topic | Antimicrobial agents Clinical pathogens Lipase-CuO nanoparticles Statistical optimization |
| url | https://doi.org/10.1186/s12896-025-00950-0 |
| work_keys_str_mv | AT emanmhandak designandassessmentoflipasecuonanoparticleconjugatesforenhancedantimicrobialefficacyagainstclinicalpathogens AT dinahamin designandassessmentoflipasecuonanoparticleconjugatesforenhancedantimicrobialefficacyagainstclinicalpathogens AT maimelhateir designandassessmentoflipasecuonanoparticleconjugatesforenhancedantimicrobialefficacyagainstclinicalpathogens |